ATE415943T1 - Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff - Google Patents
Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoffInfo
- Publication number
- ATE415943T1 ATE415943T1 AT99922371T AT99922371T ATE415943T1 AT E415943 T1 ATE415943 T1 AT E415943T1 AT 99922371 T AT99922371 T AT 99922371T AT 99922371 T AT99922371 T AT 99922371T AT E415943 T1 ATE415943 T1 AT E415943T1
- Authority
- AT
- Austria
- Prior art keywords
- cetyl alcohol
- polyproxylated
- active ingredient
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810949.9A GB9810949D0 (en) | 1998-05-22 | 1998-05-22 | Formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE415943T1 true ATE415943T1 (de) | 2008-12-15 |
Family
ID=10832479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99922371T ATE415943T1 (de) | 1998-05-22 | 1999-05-20 | Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7109246B1 (de) |
| EP (1) | EP1079804B1 (de) |
| JP (2) | JP4230109B2 (de) |
| AT (1) | ATE415943T1 (de) |
| AU (1) | AU3946899A (de) |
| CA (1) | CA2330330C (de) |
| CY (1) | CY1108659T1 (de) |
| DE (1) | DE69940015D1 (de) |
| DK (1) | DK1079804T3 (de) |
| ES (1) | ES2320054T3 (de) |
| GB (2) | GB9810949D0 (de) |
| PT (1) | PT1079804E (de) |
| WO (1) | WO1999060997A1 (de) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
| US20030153620A1 (en) | 2000-05-12 | 2003-08-14 | Meakin Timothy David | Treating eczema and/or psoriasis |
| DE60132444T2 (de) | 2000-05-12 | 2009-01-22 | Meracol Corp. Ltd., Takapuna | Behandlung von reizkolon-syndrom oder -krankheit |
| ATE381327T1 (de) * | 2000-05-12 | 2008-01-15 | Meracol Corp Ltd | Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis |
| NZ504526A (en) * | 2000-05-12 | 2003-05-30 | Meracol Corp Ltd | Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate |
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| US7767698B2 (en) * | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| ES2532906T5 (es) | 2002-10-25 | 2022-03-23 | Foamix Pharmaceuticals Ltd | Espuma cosmética y farmacéutica |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
| US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
| GB0310147D0 (en) * | 2003-05-02 | 2003-06-04 | Almond Julie E | A composition for use in the treatment of a skin condition in a subject |
| US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| AU2005244986B2 (en) * | 2004-05-19 | 2011-01-27 | Emisphere Technologies, Inc. | Topical cromolyn formulations |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| WO2008154705A1 (en) * | 2007-06-20 | 2008-12-24 | Apollo Life Sciences Limited | Transdermal delivery of active agents |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| MX2007009796A (es) | 2007-08-14 | 2009-02-25 | Cell Therapy And Technology S | Gel conteniendo pirfenidona. |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
| US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| EP2242476A2 (de) | 2008-01-14 | 2010-10-27 | Foamix Ltd. | Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| EP2482788B1 (de) | 2009-10-02 | 2022-12-14 | Journey Medical Corporation | Topische tetracyclinzusammensetzungen |
| US8685381B2 (en) | 2010-10-23 | 2014-04-01 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
| US8968755B2 (en) | 2010-10-23 | 2015-03-03 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
| MX2011007675A (es) | 2011-07-19 | 2012-07-11 | Cell Therapy And Technology S A De C V | Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas. |
| JP5930953B2 (ja) * | 2011-12-14 | 2016-06-08 | 花王株式会社 | 抗菌剤組成物の製造方法 |
| EP2827854A1 (de) * | 2012-03-19 | 2015-01-28 | Dr. August Wolff GmbH & Co. KG Arzneimittel | Verwendung von amphoteren tensiden zur prävention und behandlung von pathogenen vaginalbiofilmen bei vaginalinfektionen |
| MX346763B (es) | 2012-03-28 | 2017-03-31 | Cell Therapy And Tech S A De C V | Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné. |
| MX356551B (es) * | 2012-08-23 | 2018-06-04 | Grupo Medifarma S A De C V Star | Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné. |
| CN106535889A (zh) | 2014-02-10 | 2017-03-22 | 帕塔拉制药有限责任公司 | 用于治疗肺疾病的肥大细胞稳定剂 |
| CA2938994A1 (en) | 2014-02-10 | 2015-08-13 | Patara Pharma, LLC | Inhalable formulations of sodium cromolyn with improved bioavailability |
| EP3331522A1 (de) | 2015-08-07 | 2018-06-13 | Patara Pharma LLC | Verfahren zur behandlung von mastzellbedingten erkrankungen mit mastzellstabilisatoren |
| US10265296B2 (en) | 2015-08-07 | 2019-04-23 | Respivant Sciences Gmbh | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders |
| EP3506893A4 (de) | 2016-08-31 | 2020-01-22 | Respivant Sciences GmbH | Cromolynzusammensetzungen zur behandlung von chronischem husten aufgrund von idiopathischer pulmonaler fibrose |
| CA2978573A1 (en) | 2016-09-08 | 2018-03-08 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| AU2017339366A1 (en) | 2016-10-07 | 2019-04-11 | Respivant Sciences Gmbh | Cromolyn compositions for treatment of pulmonary fibrosis |
| MX366086B (es) | 2017-08-15 | 2019-06-27 | Cell Therapy And Tech S A De C V | Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel. |
| GB2587402B (en) | 2019-09-27 | 2023-05-10 | Hewlett Healthcare Ltd | Formulation |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3974270A (en) | 1972-11-03 | 1976-08-10 | Colgate-Palmolive Company | Pressurized composition for the production of a dry spray of mild but effective non-staining antiperspirant |
| GB1475503A (en) | 1973-12-19 | 1977-06-01 | Fisons Ltd | Topical compositions |
| GB1537047A (en) | 1975-10-03 | 1978-12-29 | Fisons Ltd | Eye ointment |
| FR2546407B1 (fr) * | 1983-05-24 | 1986-04-18 | Therapeutique Applic Sa | Medicament a activite anti-allergique pour administration locale a base d'acide n-acetyl(a,b)-aspartyl glutamique |
| EP0189861A3 (de) | 1985-01-26 | 1988-02-17 | Showa Denko Kabushiki Kaisha | Transdermaler Absorptionsbeschleuniger für ionische wasserlösliche Arzneistoffe |
| JPS6261929A (ja) * | 1985-09-13 | 1987-03-18 | Showa Denko Kk | 水溶性薬物の経皮吸収性を高めた皮膚外用剤 |
| ATE64295T1 (de) | 1985-07-10 | 1991-06-15 | Richardson Gmbh | Reinigungsschaum fuer zaehne. |
| US5190917A (en) * | 1986-12-24 | 1993-03-02 | John Lezdey | Treatment of psoriasis |
| JPS63230641A (ja) * | 1987-03-19 | 1988-09-27 | Shiseido Co Ltd | 経皮吸収促進剤及びこれを含有する皮膚外用製剤 |
| GB2202145B (en) | 1987-03-17 | 1991-01-02 | Fisons Plc | Compositions of nedocromil for dermatological use. |
| US4883792A (en) * | 1989-01-17 | 1989-11-28 | Peter Timmins | Steroid cream formulation |
| GB8912391D0 (en) * | 1989-05-30 | 1989-07-12 | Unilever Plc | Shampoo composition |
| US5100908A (en) * | 1990-03-06 | 1992-03-31 | Ss Pharmaceutical Co., Ltd. | Antimycotic external imidazole preparations |
| US5696110A (en) * | 1991-10-24 | 1997-12-09 | Merck, Sharp & Dohme, Ltd. | Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors |
| US5254109A (en) * | 1992-12-07 | 1993-10-19 | Creative Products Resource Associates, Ltd. | Separately packaged applicator pads for topical delivery of incompatable drugs |
| FR2699169B1 (fr) * | 1992-12-16 | 1995-02-03 | Oreal | Nouveaux sels d'amines primaires dérivés d'acides aminés à groupement uréthanne, et leur utilisation dans des compositions cosmétiques. |
| JPH06305934A (ja) * | 1993-04-23 | 1994-11-01 | Pola Chem Ind Inc | エアゾール型化粧料 |
| US6231844B1 (en) * | 1995-04-13 | 2001-05-15 | The Procter & Gamble Company | Nonionic surfactant foaming agents for foaming cosmetic compositions |
| JPH08319212A (ja) * | 1995-05-24 | 1996-12-03 | Kanebo Ltd | エアゾール組成物 |
| JPH09157172A (ja) | 1995-12-13 | 1997-06-17 | Lion Corp | 皮膚外用剤及び湿疹薬 |
| JPH09157161A (ja) | 1995-12-13 | 1997-06-17 | Lion Corp | 皮膚疾患治療剤 |
| WO1997027838A1 (en) * | 1996-02-02 | 1997-08-07 | Estee Lauder, Inc. | Skin smoothing compositions containing hydroxyacids and methods for using same |
| FR2745496B1 (fr) * | 1996-03-01 | 1998-04-30 | Oreal | Dispositif pressurise transparent a composition moussante comprenant des tensioactifs non-ioniques et amphoteres |
| PT884995E (pt) * | 1996-03-08 | 2002-11-29 | Disperse Ltd | Dispersoes incluindo uma espuma biliquida a base de oleo e um gel aquoso |
| US6143310A (en) * | 1996-06-27 | 2000-11-07 | The Procter & Gamble Company | Cosmetic compositions |
| US5837274A (en) * | 1996-10-22 | 1998-11-17 | Kimberly Clark Corporation | Aqueous, antimicrobial liquid cleaning formulation |
| US6150400A (en) * | 1997-06-30 | 2000-11-21 | Presutti Laboratories | Method for treating vulvar vestibulitis |
| US6150403A (en) * | 1997-10-14 | 2000-11-21 | The Procter & Gamble Company | Topical compositions for regulating the oily/shiny appearance of skin |
| US6207694B1 (en) * | 1998-07-27 | 2001-03-27 | Howard Murad | Pharmaceutical compositions and methods for managing scalp conditions |
| US6071541A (en) * | 1998-07-31 | 2000-06-06 | Murad; Howard | Pharmaceutical compositions and methods for managing skin conditions |
| US6177092B1 (en) * | 1998-11-10 | 2001-01-23 | Color Access, Inc. | Self-foaming cleansing systems |
-
1998
- 1998-05-22 GB GBGB9810949.9A patent/GB9810949D0/en not_active Ceased
-
1999
- 1999-05-20 ES ES99922371T patent/ES2320054T3/es not_active Expired - Lifetime
- 1999-05-20 AU AU39468/99A patent/AU3946899A/en not_active Abandoned
- 1999-05-20 DK DK99922371T patent/DK1079804T3/da active
- 1999-05-20 DE DE69940015T patent/DE69940015D1/de not_active Expired - Lifetime
- 1999-05-20 WO PCT/GB1999/001600 patent/WO1999060997A1/en not_active Ceased
- 1999-05-20 US US09/701,140 patent/US7109246B1/en not_active Expired - Lifetime
- 1999-05-20 AT AT99922371T patent/ATE415943T1/de active
- 1999-05-20 JP JP2000550458A patent/JP4230109B2/ja not_active Expired - Lifetime
- 1999-05-20 CA CA002330330A patent/CA2330330C/en not_active Expired - Lifetime
- 1999-05-20 GB GB9911733A patent/GB2337461B/en not_active Expired - Fee Related
- 1999-05-20 EP EP99922371A patent/EP1079804B1/de not_active Expired - Lifetime
- 1999-05-20 PT PT99922371T patent/PT1079804E/pt unknown
-
2008
- 2008-06-04 JP JP2008146698A patent/JP2008273985A/ja active Pending
- 2008-12-22 CY CY20081101484T patent/CY1108659T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69940015D1 (de) | 2009-01-15 |
| ES2320054T3 (es) | 2009-05-18 |
| GB2337461B (en) | 2003-10-01 |
| DK1079804T3 (da) | 2009-03-30 |
| JP2002530271A (ja) | 2002-09-17 |
| US7109246B1 (en) | 2006-09-19 |
| CA2330330C (en) | 2009-09-15 |
| JP2008273985A (ja) | 2008-11-13 |
| EP1079804B1 (de) | 2008-12-03 |
| WO1999060997A1 (en) | 1999-12-02 |
| JP4230109B2 (ja) | 2009-02-25 |
| GB9810949D0 (en) | 1998-07-22 |
| CA2330330A1 (en) | 1999-12-02 |
| EP1079804A1 (de) | 2001-03-07 |
| GB2337461A (en) | 1999-11-24 |
| CY1108659T1 (el) | 2014-04-09 |
| GB9911733D0 (en) | 1999-07-21 |
| PT1079804E (pt) | 2009-02-05 |
| AU3946899A (en) | 1999-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69940015D1 (de) | Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff | |
| BRPI0415858A (pt) | compostos de medicamentos terapêuticos modificados por tocoferol | |
| PT977555E (pt) | Preparacoes farmaceuticas e metodos para a sua administracao localmente | |
| AR020288A1 (es) | Emulsion aceite en agua que comprende un agente biologicamente activo micronizado y un sistema emulsionante adecuado. | |
| DE60115029D1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
| WO1996040057A3 (en) | Reverse fluorocarbon emulsion compositions for drug delivery | |
| BR9406893A (pt) | Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids | |
| DE69518334D1 (de) | Pharmazeutische aerosol welche mindestens ein zucker enthält | |
| NO20031249L (no) | Emulsjonspreparater samt konsentrater derav | |
| ECSP034883A (es) | Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen | |
| ATE269047T1 (de) | Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl | |
| YU2494A (sh) | Farmaceutska formulacija za tretiranje zavisnosti od nikotina | |
| AU5347596A (en) | External preparations for treating dermatoses | |
| DK1267831T3 (da) | Hidtil ukendt selvemulgerende system til lægemiddelindgift | |
| US20260014134A1 (en) | Composition for topical dermatological delivery | |
| DE50012930D1 (de) | Emulgatorfreie feindisperse systeme vom typ wasser-in-öl | |
| BR0109747A (pt) | Uso de 5-(2-pirazinil)-4-metil-1-2-ditiol-3-tiona (oltipraz) como um medicamento, composição farmacêutica para a prevenção e tratamento da progressão da fibrose hepática, uso de 5-(2-pirazinil)-4-metil-1, 2-ditiol-3-tiona e método para a prevenção e tratamento da progressão da fibrose e da cirrose hepática | |
| NO20073575L (no) | Farmasoytiske sammensetninger for behandling av cellulitt | |
| FR2806624B1 (fr) | Systeme huile silicone/co-solvant concentre en matiere(s) active(s) cosmetique(s) liposoluble(s), emulsion et formulation cosmetiques correspondantes | |
| MY110074A (en) | Pharmacuetical formulation. | |
| DE69228686D1 (de) | Topisch anzuwendendes arzneimittel enthaltend penciclovir | |
| DE69926633D1 (de) | Injizierbare arzneiformulierungen von partricin derivaten | |
| DE69228970D1 (de) | Dithranol enthaltendes Arzneimittel zur topischen Anwendung sowie Herstellungsverfahren | |
| DE69902925D1 (de) | Ramoplaninhaltige neue injizierbare arzneizubereitungen | |
| ATE262898T1 (de) | Formulierung mit gesteuerter wirkstoffabgabe enthaltend bupropion-hci als wirkstoff |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1079804 Country of ref document: EP |